Pneumococcal Infections
Showing 51 - 75 of 8,231
Pneumococcal Disease Trial in Japan, Korea, Republic of, Taiwan (20vPnC, Saline, 13vPnC)
Completed
- Pneumococcal Disease
- 20vPnC
- +3 more
-
Itoshima, Fukuoka, Japan
- +27 more
Dec 5, 2022
Hiv, Meningococcal Infections, Pneumococcal Infections Trial in Hvidovre (Neisseria meningitidis oligosaccharide conjugate
Recruiting
- Hiv
- +2 more
- Neisseria meningitidis oligosaccharide conjugate vaccine and recombinant protein-based vaccine
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
-
Hvidovre, DenmarkHvidovre Hospital
May 5, 2021
Streptococcus Pneumoniae Pneumonia, Streptococcus Pneumoniae Infection, Streptococcus Pneumoniae Infection Invasive Trial in
Recruiting
- Streptococcus Pneumoniae Pneumonia
- +3 more
- nasopharyngeal aspirate
-
Chía, Cundinamarca, ColombiaClinica Universidad De La Sabana
Jun 21, 2021
Pneumococcal Infection Trial (Pneumo 23® 0,5, Pneumo 23® 0,1, Prevenar13® 0,5)
Completed
- Pneumococcal Infection
- Pneumo 23® 0,5
- +2 more
- (no location specified)
Jul 31, 2021
Pneumococcal Infections Trial in United States (13-valent pneumococcal conjugate vaccine (13vPnC), 23-valent Pneumococcal
Completed
- Pneumococcal Infections
- 13-valent pneumococcal conjugate vaccine (13vPnC)
- 23-valent Pneumococcal Polysaccharide Vaccine (23vPS)
-
Huntsville, Alabama
- +25 more
Nov 11, 2021
Pneumococcal Vaccine on Nasopharyngeal Carriage
Completed
- Pneumococcal Infections
- PCV GSK1024850A
- hepatitis B vaccine or hepatitis A vaccine
-
Tampere, FinlandNational Institute for Health and Welfare
Feb 3, 2021
Pneumococcal Disease Trial in Seoul (EuPCV15, Prevenar13)
Completed
- Pneumococcal Disease
- EuPCV15
- Prevenar13
-
Seoul, Korea, Republic ofThe Catholic University of Seoul St.Mary's Hospital
Oct 6, 2021
Healthy Volunteers, Pneumococcal Disease Trial in United States (ASP3772, PCV13)
Completed
- Healthy Volunteers
- Pneumococcal Disease
- ASP3772
- PCV13
-
Bryant, Arkansas
- +16 more
Jun 2, 2022
Pneumococcal Disease Trial in Chile, United States (V116, Placebo, PCV15)
Active, not recruiting
- Pneumococcal Disease
- V116
- +3 more
-
Phoenix, Arizona
- +19 more
Dec 21, 2022
Streptococcus Pneumoniae Infection, Respiratory Syncytial Virus Infections Trial
Not yet recruiting
- Streptococcus Pneumoniae Infection
- Respiratory Syncytial Virus Infections
- (no location specified)
Aug 17, 2021
Pneumonia, Pneumococcal, Invasive Pneumococcal Disease, Acute Otitis Media Trial in Smolensk (Detection of Streptococcus
Completed
- Pneumonia, Pneumococcal
- +2 more
- Detection of Streptococcus pneumoniae strains
-
Smolensk, Russian FederationThe Interregional Association for Clinical Microbiology and Anti
Feb 8, 2021
Pneumococcal Infection Trial in Fukuoka, Kumamoto (pPCV, PNEUMOVAX™23)
Completed
- Pneumococcal Infection
- pPCV
- PNEUMOVAX™23
-
Fukuoka, Japan
- +1 more
Apr 16, 2021
HIV, Pneumococcal Infections Trial in Puerto Rico, United States (Pneumococcal Vaccine, Polyvalent (23-valent), Pneumococcal
Completed
- HIV Infections
- Pneumococcal Infections
- Pneumococcal Vaccine, Polyvalent (23-valent)
- +2 more
-
Los Angeles, California
- +32 more
Oct 27, 2021
HIV, Hepatitis B, Measles Trial in Puerto Rico, United States (Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine
Completed
- HIV Infections
- +4 more
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
- +4 more
-
Birmingham, Alabama
- +39 more
Oct 28, 2021
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Budapest, Hungary
- +33 more
Jan 11, 2023
Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of
Completed
- Mycobacterium Avium-intracellulare Infection
- +2 more
-
San Francisco, California
- +14 more
Oct 27, 2021
Intervention Performed byClinical Pharmacist on Patients at Risk
Completed
- Vaccination
-
Nîmes, FranceChu Nimes
Feb 1, 2021
Healthy Volunteers, Pneumococcal Disease Trial in United States (ASP3772, PCV13, PPSV23)
Completed
- Healthy Volunteers
- Pneumococcal Disease
- ASP3772
- +2 more
-
Banning, California
- +25 more
Apr 27, 2022
Pneumococcal Infections Trial in United States (Multivalent, Prevnar 13)
Terminated
- Pneumococcal Infections
- Multivalent
- Prevnar 13
-
Mobile, Alabama
- +47 more
Nov 29, 2021
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- PCV20
- (no location specified)
May 18, 2023
SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)
Not yet recruiting
- SARS-CoV2 Infection
- Coronavirus Infection
- mRNA- COVID-19
- Prevnar13
-
Hamilton, Ontario, CanadaMcMaster University
Jun 29, 2022
Infections, Pneumococcal, Bowel Diseases, Inflammatory Trial in France (Prevenar 13, Pneumo 23)
Unknown status
- Infections, Pneumococcal
- Bowel Diseases, Inflammatory
- Prevenar 13
- Pneumo 23
-
Amiens, France
- +7 more
Feb 3, 2021
Pneumococcal Disease Trial in Korea, Republic of (V114)
Active, not recruiting
- Pneumococcal Disease
- V114
-
Jeonju-si, Jeonrabugdo, Korea, Republic of
- +18 more
Aug 17, 2022
Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Nedlands, Western Australia, Australia
- +63 more
Nov 3, 2022
Pneumococcal Infections, Meningococcal Infections Trial in Welwyn Garden City, Gloucester (menjugate, Men C conjugate vaccine,
Completed
- Pneumococcal Infections
- Meningococcal Infections
- menjugate
- +3 more
-
Welwyn Garden City, Hertfordshire, United Kingdom
- +1 more
Sep 29, 2020